Wang Jinling
Academic Rank:

Associate Chief Physician

Education:

M.D, Ph.D

Clinical Interests:

Pediatric Endocrinology including Diabetes Mellitus(T1DM/T2DM), thyroid disease and growth development diseases. Proficient in comprehensive glucose management, especially the congenital hyperinsulinemia, with proven capability in handling complex cases and clinical guidance.



Research Field:

Dr. Wang is secialized in childhood obesity and obesity-related syndromes, short stature, congenital hyperinsulinemia(CHI), hypoglycemia, thyroid disease and other endocrine metabolic rare disorders. Actively engaged in research on childhood obesity and diabetes, having led provincial projects and participated in national studies, with many high‑quality publications and contributions to academic clinical guidelines in CHI. 

Dr. Wang has published several high quality paper, e.g. Long-term exposure to fine particulate matter components with obesity in children and adolescents in China: The age-sex disparities and key effect modifiers. Ecotoxicology and environmental safety, 290, 117773;

Covid 19 and diabetes in children: advances and strategies. Diabetol Metab Syndr. 2024;16(1):28

High Prevalence of Cardiometabolic Comorbidities Among Children and Adolescents With Severe Obesity From a Large Metropolitan Centre (Hangzhou, China). Front. Endocrinol. 13:807380.



Professional Appointments:

Secretary of Pediatrics Branch of Chinese Medical Association (CMA)

Vice Chairman, Youth Group of Endocrinology Committee of Zhejiang Association of Integrated Traditional Chinese and Western Medicine

Young Committee Member, Endocrinology Branch Zhejiang Medical Association

Committee Member of Endocrinology Group of Zhejiang Medical Doctor Association